|
69
|
233
|
4quyM |
Ycp beta5-a49s-mutant |
|
64
|
241
|
4qvlG |
Ycp in complex with bortezomib |
|
61
|
195
|
4qv4J |
Ycp beta5-m45t mutant |
|
59
|
222
|
4qw7L |
Ycp beta5-m45t mutant in complex with carfilzomib |
|
58
|
222
|
4qltH |
Ycp in complex with tripeptidic epoxyketone inhibitor 2 (pr924) |
|
58
|
222
|
4qxjL |
Ycp beta5-m45a mutant in complex with the epoxyketone inhibitor onx 0914 |
|
68
|
244
|
4qwfB |
Ycp beta5-m45i mutant in complex with carfilzomib |
|
58
|
222
|
4qvnL |
Ycp beta5-m45v mutant in complex with bortezomib |
|
62
|
196
|
4qv1N |
Ycp beta5-m45a mutant |
|
62
|
195
|
4r02J |
Ycp in complex with bsc4999 (alpha-keto phenylamide) |
|
59
|
222
|
4qz2L |
Ycp beta5-m45i mutant in complex with the epoxyketone inhibitor onx 0914 |
|
70
|
243
|
4qwiF |
Ycp beta5-a49s-mutant in complex with carfilzomib |
|
68
|
225
|
4qz4M |
Ycp beta5-a49s mutant in complex with the epoxyketone inhibitor onx 0914 |
|
58
|
222
|
4qwkH |
Ycp beta5-a49t-a50v-double mutant in complex with carfilzomib |
|
71
|
244
|
4qzzB |
Ycp in complex with omuralide |
|
66
|
242
|
4qwxD |
Ycp in complex with the epoxyketone inhibitor onx 0914 |
|
71
|
240
|
4qvpC |
Ycp beta5-m45t mutant in complex with bortezomib |
|
70
|
244
|
4qlsB |
Ycp in complex with tripeptidic epoxyketone inhibitor 11 |
|
70
|
240
|
4qwlC |
Ycp beta5-a50v mutant in complex with carfilzomib |
|
69
|
241
|
4qlsG |
Ycp in complex with tripeptidic epoxyketone inhibitor 11 |
|
54
|
204
|
4r02I |
Ycp in complex with bsc4999 (alpha-keto phenylamide) |
|
70
|
212
|
4qwsK |
Ycp beta5-c63f mutant in complex with carfilzomib |
|
66
|
212
|
4qvqK |
Ycp beta5-m45i mutant in complex with bortezomib |
|
62
|
196
|
4qv3N |
Ycp beta5-m45v mutant |
|
68
|
242
|
4r18D |
Ligand-induced lys33-thr1 crosslinking at subunit beta5 of the yeast 20s proteasome |
|
66
|
240
|
4qwrC |
Ycp beta5-c52f mutant in complex with carfilzomib |
|
67
|
250
|
4qv1A |
Ycp beta5-m45a mutant |
|
70
|
244
|
4qz6B |
Ycp beta5-a49t-a50v double mutant in complex with the epoxyketone inhibitor onx 0914 |
|
67
|
250
|
4qwrA |
Ycp beta5-c52f mutant in complex with carfilzomib |
|
73
|
212
|
4qwlK |
Ycp beta5-a50v mutant in complex with carfilzomib |
|
70
|
244
|
4qw7B |
Ycp beta5-m45t mutant in complex with carfilzomib |
|
55
|
204
|
4qwfI |
Ycp beta5-m45i mutant in complex with carfilzomib |
|
64
|
231
|
4qv8E |
Ycp beta5-c52f mutant |
|
60
|
196
|
4qz1N |
Ycp beta5-m45t mutant in complex with the epoxyketone inhibitor onx 0914 |
|
63
|
244
|
4qwjB |
Ycp beta5-a49t-mutant in complex with carfilzomib |
|
61
|
196
|
4qv8N |
Ycp beta5-c52f mutant |
|
60
|
222
|
4quyL |
Ycp beta5-a49s-mutant |
|
62
|
195
|
4qw1J |
Ycp beta5-a50v mutant in complex with bortezomib |
|
64
|
231
|
4quxE |
Ycp beta5-a49t-mutant |
|
71
|
244
|
4qvlB |
Ycp in complex with bortezomib |
|
61
|
241
|
4qv3G |
Ycp beta5-m45v mutant |
|
69
|
250
|
4qw5A |
Ycp beta5-m45a mutant in complex with carfilzomib |
|
66
|
242
|
4qluD |
Ycp in complex with tripeptidic epoxyketone inhibitor 9 |
|
61
|
196
|
4qwiN |
Ycp beta5-a49s-mutant in complex with carfilzomib |
|
62
|
195
|
4qvvJ |
Ycp beta5-a49v mutant in complex with bortezomib |
|
60
|
222
|
4qlvL |
Ycp in complex with tripeptidic epoxyketone inhibitor 17 |
|
63
|
241
|
4qzzG |
Ycp in complex with omuralide |
|
62
|
241
|
4qz2G |
Ycp beta5-m45i mutant in complex with the epoxyketone inhibitor onx 0914 |
|
56
|
204
|
4qv8I |
Ycp beta5-c52f mutant |
|
71
|
243
|
4qz4F |
Ycp beta5-a49s mutant in complex with the epoxyketone inhibitor onx 0914 |
